menu
FR | EN
Digital Healthcare Community
Certified Medical Tourism ProfessionalBest Medical Travel Agency 2015Best use of technology in Medical Travel 2017

French study shows vaccine dramatically reduces severe COVID risk

14/10/2021

French study shows vaccine dramatically reduces severe COVID risk

A large French study involving 22 million people has shown that COVID vaccines dramatically reduce a person’s risk of being severely impacted by the disease.


While being vaccinated doesn’t guarantee you won’t catch COVID or indeed become ill, it does, however, reduce your risk of being hospitalised or dying by as much as 90 per cent.


The study, published Monday, also found two-dose vaccines, such as Pfizer-BioNTech, Moderna and Oxford-AstraZeneca, protect against the worst effects of the so-called Delta variant. For people aged 75 and older, such vaccines offered 84 per cent protection. This figure rose to 92 per cent for people 50 to 75. The results were the same for each vaccine manufacturer.


“The vaccine was never really intended to stop the disease,” says Dr. Ulysses Wu, Hartford HealthCare’s System Director of Infection Disease and Chief Epidemiologist. “It was a very nice side effect that we were preventing disease, but it’s main purpose is to prevent the morbidity and mortality should we get the disease. It was really to take a deadly disease and turn it into the common cold.”


The study was conducted by a scientific group set up by France’s health system (Epi-Share), its national insurance fund (l’Assurance Maladie) and its medicine agency (ANSM).


N.B. The Johnson & Johnson vaccine (Janssen) was not included in the research due to an insufficient number of patients for comparison.


* Image by Surprising_Shots from Pixabay

expand_less